The 340B Rebate Pilot Is Back at Under 5.5% of Sales, Rebuilt to Survive the Court That Killed It
HRSA restarted the 340B rebate pilot at under 5.5% of sales, wrapped in 21 pages of answers to the court that vacated the first one.
340B Rebate
340B Rebate Model Pilot Clears HRSA Approval, Hospitals Warn of New Burdens
HRSA’s approval of eight manufacturers for its 340B Rebate Model Pilot signals a major pricing shift.